Literature DB >> 11535409

Melanin content of cultured human melanocytes and UV-induced cytotoxicity.

S M De Leeuw1, N P Smit, M Van Veldhoven, E M Pennings, S Pavel, J W Simons, A A Schothorst.   

Abstract

Cultured melanocytes originating from persons with different skin phototypes were utilized for measurement of endonuclease sensitive sites induced by UVB and the determination of cell survival after UVA or UVB irradiation. During culture, the melanocytes largely maintained their phenotypic characteristics according to their original skin phototype. Total melanin concentrations were 4.9 times higher in the darker skin phototype (IV-VI) melanocytes when compared to the cells from lighter skin phototypes (I-III). Also phaeomelanin contents were higher (2.5 times) in the skin phototype (IV-VI) melanocytes which implies that the cells from light skin types contain less melanin, but a relatively high proportion of phaeomelanin. After UVB irradiation a stronger induction of endonuclease sensitive sites was found for melanocytes with a lower level of total melanin and a high content of pheomelanin. By measuring the clone forming ability in different melanocyte cultures after UVB irradiation, significant better survival was found in case of the cells with the higher melanin content. Despite the large variations in melanin content, no significant difference in survival after UVA irradiation could be demonstrated in this way. Our results suggest a protective effect of melanin for UVB and indicate the importance of the measurements of melanin content and composition when different parameters of UV-induced damage are studied in melanin producing cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535409     DOI: 10.1016/s1011-1344(01)00168-3

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  8 in total

1.  UVB Dependence of Quantum Dot Reactive Oxygen Species Generation in Common Skin Cell Models.

Authors:  Luke J Mortensen; Renea Faulknor; Supriya Ravichandran; Hong Zheng; Lisa A DeLouise
Journal:  J Biomed Nanotechnol       Date:  2015-09       Impact factor: 4.099

2.  Iris color and associated pathological ocular complications: a review of epidemiologic studies.

Authors:  Hong-Peng Sun; Yi Lin; Chen-Wei Pan
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

Review 3.  Anti-photoaging and photoprotective compounds derived from marine organisms.

Authors:  Ramjee Pallela; Yoon Na-Young; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-04-08       Impact factor: 5.118

4.  Mitf dosage as a primary determinant of melanocyte survival after ultraviolet irradiation.

Authors:  Thomas J Hornyak; Shunlin Jiang; Esther A Guzmán; Beth N Scissors; Chinisada Tuchinda; Hongbin He; James D Neville; Faith M Strickland
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-03       Impact factor: 4.693

5.  Visible light is a better co-inducer of apoptosis for curcumin-treated human melanoma cells than UVA.

Authors:  Stephan Buss; Jadranka Dobra; Kerstin Goerg; Stephanie Hoffmann; Stefan Kippenberger; Roland Kaufmann; Matthias Hofmann; August Bernd
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

6.  Ultraviolet B, melanin and mitochondrial DNA: Photo-damage in human epidermal keratinocytes and melanocytes modulated by alpha-melanocyte-stimulating hormone.

Authors:  Markus Böhm; Helene Z Hill
Journal:  F1000Res       Date:  2016-05-12

Review 7.  Photoprotection role of melanin in the human retinal pigment epithelium. Imaging techniques for retinal melanin.

Authors:  Marina Istrate; Brigitha Vlaicu; Marioara Poenaru; Mihai Hasbei-Popa; Mădălina Casiana Salavat; Daniela Adriana Iliescu
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

Review 8.  Iris Colour and the Risk of Developing Uveal Melanoma.

Authors:  Laurien E Houtzagers; Annemijn P A Wierenga; Aleid A M Ruys; Gregorius P M Luyten; Martine J Jager
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.